Company Announcement: Approval for trading of 1,59,06,292 additional shares of Pfizer Limited
Mumbai, January 12, 2015 :
The Scheme of Amalgamation between Wyeth Limited and Pfizer Limited and their respective shareholders and creditors (Scheme) was sanctioned by the Hon'ble Bombay High Court vide its order dated October 31, 2014. The Scheme has become effective on December 1, 2014.
Thereafter, the Company had applied to the BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE) seeking their approval under the Listing Agreement with respect to listing and admission to trading of additional 1,59,06,292 equity shares of Rs. 10/- each allotted to the shareholders of erstwhile Wyeth Limited pursuant to the Scheme. The Company has received the listing approval from NSE on December 26, 2014 and from BSE on January 5, 2015. The Company has also dispatched the share certificates to the physical shareholders and shares in demat mode were credited to the respective shareholders' demat account. T he Company has then submitted confirmations to BSE and NSE to that effect. Further, on January 9, 2015, BSE and NSE have granted their approval for trading of such additional shares of the Company. Accordingly, trading of the additional shares of the Company allotted to the shareholders of erstwhile Wyeth Limited has commenced from January 12, 2015.
Thanking you
Yours truly
For PFIZER LIMTIED
Prajeet Nair
Company Secretary
distributed by
 |